Lacrimal Gland Uptake of ⁶⁷Ga-gallium Citrate Correlates with Biopsy Results in Patients with Suspected Sarcoidosis

References

• Cox CE, Davis-Allen A, Judson MA. Sarcoidosis. Med Clin North Am. 2005;89:817–828
   PubMed Web of Science ®Google Scholar
• Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885–1889
   PubMed Web of Science ®Google Scholar
• Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–755
   PubMed Web of Science ®Google Scholar
• Papadia M, Herbort CP, Mochizuki M. Diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm. 2010;18:432–441
   PubMed Web of Science ®Google Scholar
• Neville E. Sarcoidosis: the clinical problem. Postgrad Med J. 1988;64:531–535
   PubMedGoogle Scholar
• Larson SM, Rasey JS, Allen DR, et al. Common pathway for tumor cell uptake of gallium-67 and iron-59 via a transferrin receptor. J Natl Cancer Inst. 1980;64:41–53
   PubMed Web of Science ®Google Scholar
• Miller BH, Rosado-de-Christenson ML, McAdams HP, Fishback NF. Thoracic sarcoidosis: radiologic-pathologic correlation. Radiographics. 1995;15:421–437
   PubMed Web of Science ®Google Scholar
• Israel HL, Albertine KH, Park CH, Patrick H. Whole-body gallium 67 scans. Role in diagnosis of sarcoidosis. Am Rev Respir Dis. 1991;144:1182–1186
   PubMed Web of Science ®Google Scholar
• Abe S, Munakata M, Nishimura M, et al. Gallium-67 scintigraphy, bronchoalveolar lavage, and pathologic changes in patients with pulmonary sarcoidosis. Chest. 1984;85:650–655
   PubMedGoogle Scholar
• Israel HL, Gushue GF, Park CH. Assessment of gallium-67 scanning in pulmonary and extrapulmonary sarcoidosis. Ann N Y Acad Sci. 1986;465:455–462
   PubMedGoogle Scholar
• Klech H, Kohn H, Kummer F, Mostbeck A. Assessment of activity in sarcoidosis: sensitivity and specificity of 67gallium scintigraphy, serum ACE levels, chest roentgenography, and blood lymphocyte subpopulations. Chest. 1982;82:732–738
   PubMed Web of Science ®Google Scholar
• Rohatgi PK, Baier H. Quantitative gallium scanning in pulmonary sarcoidosis. Respiration. 1983;44:304–313
   PubMedGoogle Scholar
• Sulavik SB, Spencer RP, Palestro CJ, et al. Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis. Chest. 1993;103:403–409
   PubMed Web of Science ®Google Scholar
• Baughman RP, Shipley R, Eisentrout CE. Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis. Lung. 1987;165:371–377
   PubMed Web of Science ®Google Scholar
• Mana J. Nuclear imaging. 67gallium, 201thallium, 18F-labeled fluoro-2-deoxy-d-glucose positron emission tomography. Clin Chest Med. 1997;18:799–811
   PubMedGoogle Scholar
• Mana J. Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr Opin Pulm Med. 2002;8:457–463
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Yavitz EQ, O'Connor GR, Barth RA. Lacrimal gland uptake of gallium citrate Ga 67. Am J Ophthalmol. 1981;92:16–20
   PubMed Web of Science ®Google Scholar
• Karma A, Poukkula A, Ruokonen A. Gallium 67 citrate scanning in patients with lacrimal gland and conjunctival sarcoidosis: a report on three cases. Acta Ophthalmol (Copenh). 1984;62:549–555
   PubMedGoogle Scholar
• Karma A, Poukkula AA, Ruokonen AO. Assessment of activity of ocular sarcoidosis by gallium scanning. Br J Ophthalmol. 1987;71:361–367
   PubMedGoogle Scholar
• Mochizuki T, Ichijo K, Takehara Y, Nakamura M. Gallium-67-citrate scanning in patients with sarcoid uveitis. J Nucl Med. 1992;33:1851–1853
   PubMedGoogle Scholar
• Rohatgi PK, Singh R, Vieras F. Extrapulmonary localization of gallium in sarcoidosis. Clin Nucl Med. 1987;12:9–16
   PubMedGoogle Scholar
• Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med. 2006;47:1571–1576
   PubMed Web of Science ®Google Scholar
• Frohman LP, Guirgis M, Turbin RE, Bielory L. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuroophthalmol. 2003;23:190–197
   PubMed Web of Science ®Google Scholar
• Frohman LP, Grigorian R, Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation, and management. J Neuroophthalmol. 2001;21:132–137
   PubMed Web of Science ®Google Scholar
• Sulavik SB, Spencer RP, Weed DA, et al. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med. 1990;31:1909–1914
   PubMedGoogle Scholar
• Sulavik SB, Spencer RP, Castriotta RJ. Panda sign—avid and symmetrical radiogallium accumulation in the lacrimal and parotid glands. Semin Nucl Med. 1991;21:339–340
   PubMedGoogle Scholar
• Kurdziel KA. The panda sign. Radiology. 2000;215:884–885
   PubMedGoogle Scholar
• Lauver JW, Gooneratne NS. Lacrimal, parotid and mediastinal uptake of gallium 67 in sarcoidosis. Br J Radiol. 1979;52:582–584
   PubMed Web of Science ®Google Scholar
• Nosal A, Schleissner LA, Mishkin FS, Lieberman J. Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. Ann Intern Med. 1979;90:328–331
   PubMed Web of Science ®Google Scholar
• Power WJ, Neves RA, Rodriguez A, et al. The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology. 1995;102:2007–2011
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Hanada A, Horie S, et al. Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol. 2007;51:121–126
   PubMed Web of Science ®Google Scholar
• Hosoya S, Kataoka M, Nakata Y, et al. Clinical features of 125 patients with sarcoidosis: Okayama University Hospital review of a recent 10-year period. Acta Med Okayama. 1992;46:31–36
   PubMed Web of Science ®Google Scholar
• van Unnik JG, van Royen EA, Alberts C, van der Schoot JB. A method of quantitative 67Ga scintigraphy in the evaluation of pulmonary sarcoidosis. Eur J Nucl Med. 1983;8:351–353
   PubMedGoogle Scholar
• Bisson G, Drapeau G, Lamoureux G, et al. Computer-based quantitative analysis of gallium-67 uptake in normal and diseased lungs. Chest. 1983;84:513–517
   PubMedGoogle Scholar
• Fajman WA, Greenwald LV, Staton G, et al. Assessing the activity of sarcoidosis: quantitative 67Ga-citrate imaging. AJR Am J Roentgenol. 1984;142:683–688
   PubMed Web of Science ®Google Scholar
• Rohatgi PK, Bates HR, Noss RW. Computer-assisted sequential quantitative analysis of gallium scans in pulmonary sarcoidosis. Eur J Respir Dis. 1985;66:248–255
   PubMedGoogle Scholar
• Bourguet P, Delaval P, Herry JY. Direct quantitation of thoracic gallium-67 uptake in sarcoidosis. J Nucl Med. 1986;27:1550–1556
   PubMedGoogle Scholar
• Alberts C, van der Schoot JB. Standardized quantitative 67Ga scintigraphy in pulmonary sarcoidosis. Sarcoidosis. 1988;5:111–118
   PubMedGoogle Scholar
• Myslivecek M, Husak V, Kolek V, et al. Absolute quantitation of gallium-67 citrate accumulation in the lungs and its importance for the evaluation of disease activity in pulmonary sarcoidosis. Eur J Nucl Med. 1992;19:1016–1022
   PubMedGoogle Scholar
• Brantley SD, Orzel JA, Weiland FL, Bower JH. Parotid gland biopsy and 67Ga imaging correlation in systemic sarcoidosis. Chest. 1987;91:403–407
   PubMedGoogle Scholar